You do not have permission to edit this page, for the following reasons:

This IP address has been blocked from editing Wikipedia.
This does not affect your ability to read Wikipedia pages.
Most people who see this message have done nothing wrong. Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.

The IP address or range 34.203.0.0/16 has been blocked (disabled) by ‪ST47‬ for the following reason(s):

The IP address that you are currently using has been blocked because it is believed to be a web host provider. To prevent abuse, web hosts may be blocked from editing Wikipedia.
You will not be able to edit Wikipedia using a web host provider because it hides your IP address, much like a proxy or VPN.
We recommend that you attempt to use another connection to edit. For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in.
If you do not have any other way to edit Wikipedia, you will need to request an IP block exemption.

How to appeal if you are confident that your connection does not use a web host's IP address:
If you are confident that you are not using a web host, you may appeal this block by adding the following text on your talk page: ((unblock|reason=Caught by a web host block but this host or IP is not a web host. My IP address is _______. Place any further information here. ~~~~)). You must fill in the blank with your IP address for this block to be investigated. Your IP address can be determined here. Alternatively, if you wish to keep your IP address private you can use the unblock ticket request system. There are several reasons you might be editing using the IP address of a web host (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host.

Administrators: The IP block exemption user right should only be applied to allow users to edit using web host in exceptional circumstances, and they should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a CheckUser needs to take a look at the account. This can be requested most easily at SPI Quick Checkuser Requests. Unblocking an IP or IP range with this template is highly discouraged without at least contacting the blocking administrator.

This block will expire on 00:10, 24 April 2026.

Even when blocked, you will usually still be able to edit your user talk page, as well as email administrators and other editors.

For information on how to proceed, please read the FAQ for blocked users and the guideline on block appeals. The guide to appealing blocks may also be helpful.

Other useful links: Blocking policy · Help:I have been blocked
Your IP address is in a range that has been blocked on all Wikimedia Foundation wikis. The block was made by ‪Jon Kolbert‬. The reason given is Open proxy/Webhost: See the help page if you are affected .
- Start of block: 05:38, 21 February 2024
- Expiry of block: 05:38, 21 February 2029
Your current IP address is 34.203.203.107. The blocked range is 34.203.0.0/16. Please include all above details in any queries you make. If you believe you were blocked by mistake, you can find additional information and instructions in the No open proxies global policy. Otherwise, to discuss the block please post a request for review on Meta-Wiki. You could also send an email to the stewards VRT queue at stewards@wikimedia.org including all above details.

You can view and copy the source of this page:

((Multiple issues|
((Cleanup rewrite|date=May 2023))
((More citations needed|date=May 2023))
))
[[Pharmacy]] in [[China]] involves the activities engaged in the preparation, standardization and dispensing of [[drug]]s, and its scope includes the cultivation of [[plant]]s that are used as drugs, the [[Chemical synthesis|synthesis]] of chemical compounds of medicinal value, and the analysis of medicinal agents. [[Pharmacist]]s in China are responsible for the preparation of the [[dosage form]]s of drugs, such as tablets, capsules, and sterile solutions for injection. They compound physicians', dentists', and veterinarians' [[Medical prescription|prescription]]s for drugs. [[Pharmacology|Pharmacological]] activities are also closely related to pharmacy in China.

There are two main streams of [[pharmaceutical practice]] in [[China]], [[traditional Chinese medicine]] (TCM) and modern [[pharmacy]]. [[Hospital pharmacy|Hospital]] and [[community pharmacy|community]] pharmacies are responsible for the dispensing of medicinals used for both streams of pharmaceutical practice.

Around fifty colleges of pharmacy offer [[pharmacy education]], half of which provide a Western medicine approach and the other half traditional Chinese medicine. Both types of colleges offer a four-year curriculum with options for specialization. Graduate study is also available. Most graduates work in hospital pharmacies. Hospital pharmacies participate in the bulk manufacture of drugs and [[parenteral]] fluids. A bulk dispensing system is used by some hospitals; individual patient doses are dispensed in others.

Recently, [[clinical pharmacy]] services in China have been developed and training courses begun. Curricula with specialization in clinical pharmacy have also been established by colleges of pharmacy.

It is anticipated that through increased awareness of the potential contribution of [[pharmacist]]s in China's health-care system, more opportunities for educating pharmacists would be made available to meet the vast need of the country. Development of clinical pharmacy services have also been expected to improve the quality of care provided.

== Ancient history ==
The beginnings of pharmacy in China are ancient (see [[Chinese alchemy]]). According to legend, [[Shennong]] (about 2000 BCE) who sought out and investigated the medicinal value of several hundred herbs. He reputed to have tested many of them on himself, and to have written the first Pen T-Sao, or native herbal, recording 365 drugs. He is said to have tasted hundreds of [[herb]]s to test their medical value.

The most well-known work attributed to Shennong is ''The Divine Farmer's Herb-Root Classic''. This work is considered to be the earliest Chinese [[pharmacopoeia]]. It includes 365 medicines derived from minerals, plants, and animals. Shennong is credited with identifying hundreds of medical (and poisonous) [[herb]]s by personally testing their properties, which was crucial to the development of [[traditional Chinese medicine]].

Still worshiped by native Chinese drug guilds as their patron god, Shennong conceivably examined many herbs, barks, and roots brought in from the fields, swamps, and woods that are still recognized in Pharmacy today. The "''[[Bagua (concept)|bagua]]''" is a mathematical design symbolizing creation and life. Medicinal plants include [[podophyllum]], [[rhubarb]], [[ginseng]], [[stramonium]], [[cinnamon bark]], and, ''[[ma huang]]'', or [[Ephedra (plant)|Ephedra]].

== Separation of prescribing from dispensing ==
Unlike the prevailing practice in other, particularly Western countries, the duties of the pharmacist and [[physician]] are not entirely separated. Chinese doctors are allowed to dispense drugs themselves and the practice of pharmacy is sometimes integrated with that of the physician, particularly in traditional Chinese medicine. The idea of separating the two professions has been debated as the trend for specialization has increased in the [[health sciences]]. Other countries such as South Korea, Japan and Taiwan have successfully separated the jurisidications to legally separate the practice of prescribing from the practice of dispensing. That legislation has also specified that only pharmacists may supply scheduled pharmaceuticals to the public, and that pharmacists cannot form business partnerships with physicians or give them "kickback" payments. Possible reform for this area is being considered by the Chinese regulatory authorities.

== Pharmacist role ==
Since the economic reform period of the 1980s, the development of the Chinese [[pharmaceutical industry]] has led to the introduction of new and effective drug substances. It also changed the role of the pharmacist. The scope for extemporaneous compounding of medicines was much diminished and with it the need for the manipulative skills that were previously applied by the pharmacist to the preparation of bougies, cachets, pills, plasters, and liquids. Pharmacists continue, however, to fulfill the prescriber's intentions by providing advice and information; by formulating, storing, and providing correct [[dosage form]]s; and by assuring the [[efficacy]] and quality of the dispensed or supplied medicinal product.

In the future, pharmacists are expected to become more integral within the health care system. Rather than only dispensing medication and other routine duties, pharmacists are to be involved more in patient care with their particular knowledge and skills.

== Hospital pharmacy ==
Since 1949, [[health care]] in China has improved. The number of [[hospital]]s has increased. While medicines previously were scarce, China now produces approximately 75 percent of the drugs it needs. China has a long history of traditional medicine; although there are attempts to integrate the concepts of traditional and Western medicine, the practices are still segregated. All hospital pharmacies in China have the responsibilities to guarantee the safe and effective use of drugs within the hospital and to do research. Even though Chinese factories manufacture many pharmaceutical products, the hospital pharmacy must manufacture many more.

Hospitals have established Agreed Prescription programs, whereby drugs are manufactured in large batches, repackaged, and distributed to other hospital pharmacies in the area if needed. Quality is assessed chemically and by modern techniques when equipment is available. Most large hospitals now have automated facilities to manufacture [[Asepsis|sterile]] solutions. Each hospital has a medical supply committee that supervises the procurement of medical supplies and the reasonable use of drugs.

A government resolution mandates that every hospital pharmacy do [[research]]. A primary focus of their research is the integration of traditional and Western medicine. Concepts of traditional and Western medicine are taught in separate [[pharmacy schools]]. Most pharmacy undergraduate programs are four years, but some schools recently changed to five years. Challenges for hospital pharmacists in China have been to develop the theoretical and technological knowledge of pharmacy, and to expand the scientific and technical information system that is necessary to do research.

== Education ==
((see also|Pharmacy school))

The course of instruction leading to a [[Bachelor of Science]] in pharmacy ([[BPharm]]) extends at least four years. The first and frequently the second year of training, embracing general education subjects, are often provided by a school of arts and sciences. Many institutions also offer graduate courses in pharmacy and cognate sciences leading to the degrees of [[Master of Science]] and [[Doctor of Philosophy]] in [[pharmacy]], [[pharmacology]], or related disciplines. These advanced courses are intended especially for those who are preparing for careers in research, manufacturing, or teaching in the field of pharmacy.

Since the treatment with drugs encompasses a wide field of knowledge in the biological and physical sciences, an understanding of these sciences is included for pharmaceutical training. The basic four-year curriculum in the colleges of pharmacy, for example, embraces [[physics]], [[chemistry]], [[biology]], [[bacteriology]], [[physiology]], [[pharmacology]], and many other specialized courses. As the pharmacist is engaged in a [[business]] as well as a profession, special training is provided in merchandising, accounting, computer techniques, and pharmaceutical jurisprudence.

Subjects:
*[[Clinical pharmacy]]
*[[Pharmacy practice]]
*[[Pharmaceutical care]]
*[[Pharmacy administrative sciences]]
*[[Pharmacotherapy]]
*[[Pharmacoeconomics]]
*[[Pharmacogenetics]]
*[[Pharmacogenomics]]
*[[Pharmacoepidemiology]]

Reforms made to provide an individualized, state-of-the-art learning environment that facilitates the development of students' knowledge, skills, attitudes and behaviors needed by the pharmacy profession and society at-large, so they provide high quality pharmaceutical care:

*critical-thinking,
*problem-solving,
*communication skills,
*technology skills
*patient-care skills.
*a pharmacy-focused basic science curriculum that is integrated with patient assessment, a problem-based learning case study sequence, an outcome-oriented assessment plan, and structured experiential clerkships in each year of the program.

Competency-based education with an emphasis on patient-oriented practice and accountability are the current and future trends in pharmacy education. Reforms have been made to promote state-of the-art pharmaceutical sciences in curricula when at the same time there is a shift from product-oriented to patient-oriented pharmacy education and practice. There has seen a radical change in curriculum and organisational structure focussing on problem-oriented and student centred educational methods, in order to optimally prepare future practitioners and scientists.

===Development of pharmaceutical education===
Higher pharmaceutical education in China has been developing rapidly. Since 1978, a series of reforms have been carried out in teaching management and training model. Many changes have been made in the fields of pharmaceutical education, such as characteristic higher education of traditional Chinese pharmacy, the education of newly emerging clinical pharmacy, the trend of combination of traditional Chinese pharmacy with Western pharmacy, the reform of four year university education and postgraduate education.<ref>Editorial Board of China Pharmacy Yearbook, (China Pharmacy yearbook), p . 94 (1993)</ref>

===Higher education of traditional Chinese pharmacy===
Traditional Chinese pharmacy has had a history of thousands of years. The scientific therapeutic effects of [[traditional Chinese materia medica]] have attracted great attention both at home and abroad. In the recent 20–30 years there has appeared a tendency to "return to nature" owing to the [[Toxicity|toxic]] and [[adverse effect|side effects]] of chemical medicines and the drug-induced diseases caused by them. On the other hand, the traditional Chinese medicine and pharmacy have attracted more attention because of the difficulty in searching for and synthesizing new compounds. Only by [[modernization]] of traditional Chinese materia medica can its use become global. The modernization of traditional Chinese materia medica means studying the theories and the basic content of traditional Chinese pharmacy applying the knowledge of modern science and technology. The information on Chinese materia medica should be expressed in modern scientific indexes, terms, and include standardized methods of quality measurement and modernized forms of medicines. The task of higher education of traditional Chinese pharmacy is to train high-level personnel to fulfill the modernization of traditional Chinese pharmacy.

There are five specialties of traditional Chinese pharmacy and 38 programs in China. These specialties have training targets, core courses and job orientations. All specialties have two common characteristics in their core courses: (i) the basic theories of traditional Chinese medicine, traditional Chinese pharmacy and preparations of traditional Chinese materia medica; and (ii) attention to teaching basic knowledge of modern science that includes advanced mathematics, computer application, mathematical [[statistics]], [[physics]], [[physical chemistry]] and [[analytical chemistry]].

===Education of emerging Clinical Pharmacy===
With the development of medicine and pharmacy more domestic and foreign medicines have come into the China's medical market. Among them are a number of new drugs and their new [[drug form]]s. These have become a burden for the clinical physicians to grasp the knowledge of their application and study the rational clinical use and safety for their [[therapeutic effect]]s. They have to depend on [[pharmacist]]s to solve these problems. This is why the education of clinical pharmacy had begun to attract more attention. In 1987 the National Educational Committee approved the start of the specialty of [[clinical pharmacy]]. Since the beginning four classes of the students were enrolled. They were five-year system students. The clinical pharmacists educated in China are engaged in the clinical application of drugs and monitoring their therapeutic effects. The first class of these students in the clinical pharmacy specialty graduated in 1994.

Other pharmaceutical universities and colleges (departments) are also taking steps to establish a specialty of clinical pharmacy, adding [[correspondence course]]s, beginning [[postgraduate]] classes in clinical pharmacy, and opening short courses for [[advanced study]] to help pharmacists working in hospitals who have been engaged in clinical application of drugs for many years. This has promoted the development of clinical pharmacy in China.<ref>Editorial Board of China Pharmacy Yearbook, (1996) pp. 107–111.</ref>

===Combination of traditional and modern pharmacy===
Two kinds of pharmacy have existed in China since Western medicine and pharmacy spread into China more than one hundred years ago: (i) [[traditional Chinese medicine|traditional Chinese pharmacy]], and (ii) [[pharmacy|Western pharmacy]]. They are two different pharmaceutical systems with different theories and approach to research. The former is based on a comprehensive study which emphasizes entirety, mobility and vagueness, while the latter is based on analytical study which emphasizes microconception, stability and accuracy. Both systems have advantages and both have limitations. It has been thought in China that if these two systems are combined, a new system will be formed towards the improvement of the life science of man.

Since the foundation of the [[People's Republic of China]] considerable work has been done by grouping and summarizing previous experiences. The progress made in this field includes:

1. The research of [[active ingredient]]s of traditional Chinese [[herbalism|medicinal herbs]].

The [[chemical structure]]s of the active ingredients of hundreds of herbs have been made clear. Now some of the active ingredients can be synthesized or modified in chemical structure. Not only have new drugs been researched but also the therapeutic mechanism of traditional Chinese medicinal herbs have been clarified, which promotes the combination of traditional Chinese pharmacy with Western pharmacy.

2. The research of the compound preparations of traditional Chinese medicinal herbs.

The compound preparations of traditional Chinese medicinal herbs are the most popular recipes used by doctors of traditional Chinese medicine. There are 12,000 recipes in ''[[Ben Cao Gangmu]]'' (the "Compendium of Materia Medica"). The composition of these recipes has a characteristic regularity and makes the ingredients in every recipe effective as a whole. This corresponds not only to [[symptom]]s but also the [[syndrome]]s of the whole body.  The modern study of the compound preparations of traditional Chinese materia medica is an important content of the modernization of traditional Chinese medicine and one of the prerequisites of the combination of traditional Chinese pharmacy with Western pharmacy. The selection of the ingredients and forms of preparations, production procedures (including the form modification), [[quality control]], clinical and pharmacological experiments have been studied systematically. A number of new drugs and their new forms and giving scientific explanation to the regularity in recipe composition have been developed. Some diseases, whose scientific indexes have been known in their treatment by Western medicine, have been treated and reportedly cured by using traditional Chinese medicine. The therapeutic effects of the compound preparations of some traditional Chinese materia medica can be compared clinically with those of Western medicines and are expressed in modern scientific indexes. This provides the material foundation of the compound preparations of traditional Chinese materia medica and the modernization of the expression of their therapeutic activities.

There have been continuing efforts to combine traditional Chinese pharmacy with Western pharmacy. In order to train the personnel who are able to engage in the combination of traditional Chinese pharmacy and Western pharmacy, educational opportunities have been developed to teach and research the traditional Chinese pharmacy and Western pharmacy in combination. The students are trained to have a foundation and experimental skills in both traditional Chinese pharmacy and Western pharmacy (including the knowledge and skills of clinical medicine). There are two approaches for this training: (i) a six-year system of the specialty of combining traditional Chinese pharmacy and Western pharmacy granting master's degree; and (ii) a two-year system of the postbaccalaureate degree class offering bachelor's degree pharmaceutical graduates another bachelor's degree in traditional Chinese pharmacy.

===4-year undergraduate education===
During the first years of the foundation of the People's Republic of China, the courses and the management model of the semester system were introduced from the [[Soviet Union]]. This met the needs of the planned economy for China at that time. This model emphasized the dependence of administrative measures planned by the State, e.g., the enrollment and assignment of students, the arrangement of courses. Such a highly centralized and unified way of job could not stimulate the vigor and vitality of universities in running schools. Since 1978 there have been rapid and profound changes in China which have produced differences between the previous educational model and the pace of the reform of the economic system. These are as follows:

Because of the launching of the [[socialist market economy]] the students with narrow specific knowledge trained by the semester system could not meet the demands of the personnel with broad specific knowledge needed by the market economy. Further, the number of the university students in China has been insufficient to meet the pharmacy [[manpower]] needs. Some areas and units refuse to employ graduates assigned by the Chinese government because the specialties of these graduates do not meet their specific requirements. The employing units need the students who are expert in their specialty and have good adaptability to various jobs. Students are encouraged to elect more optional courses and to learn what is needed by the employer market on their own initiative.

The system of courses has become more comprehensive. The world, including that of pharmacy, is faced with the great challenge of highly developed and -complex technology. As a result, complex cross-disciplinary sciences have appeared. The number of hours, however, is limited. Therefore, new required subjects of semester system length have been added to the curriculum making it less possible to increase the elective subjects with new content.

The credit system has solved some of the problems in the semester system. The foundation has been emphasized and specialty de-emphasized, as follows:

1. Students who major in different fields of pharmacy have taken common basic courses such as mathematics, chemistry, biology and computer sciences. The [[lecture]] hours and requirements of these courses have been arranged in a unified way. This has given a broad and solid foundation of basic theories from these courses to all pharmacy students. The curricula based on the credit system is stipulated to include less than 70 percent of required courses and increase the proportion of optional courses which account for 20–30 percent of all the courses offered. This gives the students the freedom to choose what interests them and what they need in their future jobs.

2. According to the different programs the specific subjects were divided into modules. For example, students who learn analysis and the [[assay]] of drugs may elect [[spectroanalysis]], pharmaceutical analysis and other courses. The students who learn [[hospital pharmacy]] may elect hospital pharmaceutical preparations, [[clinical pharmacology]] and other related topics. Students can choose the subjects in the modules according to the requirements of the country's construction. the needs of social development and their individual interest. The bright students have been allowed to choose more subjects and finish the study earlier than those who are academically challenged or those who take part-time study.

By carrying out the credit system the Chinese higher pharmaceutical education have trained more students who are expert in their specialty and have multiple skills by the combination of liberal and professional education.

===Postgraduate education===
In 1995 there were 113 MSc programs and 48 PhD programs. The pharmaceutical specialties had 136 professors who served as advisors of doctoral candidates. The number of the students enrolled in 1995 to pursue the master's degree increased by 70 percent and the students pursuing the PhD were 277.5 percent more than in 1990. In order to face the economic development in China, some measures have been taken to improve the postgraduate education. For example, the employers, such as hospitals, factories, research institutions, companies and others who need professional personnel can designate the employees with practical experience to be trained in universities. These employees will return to their employment after graduation. The professors in the universities combine with the researchers to instruct these students. The subject of their thesis is usually related to their job. The employers provide laboratories and facilities as well as some of the tuition. This is an approach to train personnel, which benefits universities, employers and students.<ref>Liu, L., Yue, Z. and Li, P., "Review and prospect of postgraduate education," Pharmaceutical Education, 8(2), 33-34(1992)</ref>

In order to promote scientific research and the training of highly qualified researchers, mobile research stations have been approved by the government. Thus far in China, there have been six such stations where postdoctoral students are carrying on their research in five pharmaceutical specialties. These stations play an important role in stimulating academic exchange, training high-level professional personnel and attracting the overseas-trained students to come back.<ref>Liang, R., Gui, K. and Ju, S., "Conception and implementation of the reform in training pharmaceutical professional personnel," ibid., 13(1), 5-7(1997)</ref>

Although the postgraduate education of pharmaceutical sciences has developed quickly, the number of the postgraduates is still limited. The proportion of postgraduates to undergraduates is 0.05:1. Many fields, such as pharmaceutical research, pharmaceutical industry and commerce, inspection and clinical application of drugs, pharmaceutical education and management, need graduates with advanced degrees, but these specialties have produced relatively few graduates for several years.<ref>Jiang, K., "Comparison between the systems of postdoctoral study in China and the USA," Academic Degrees and Graduate Education, 2, 70-73(1997)</ref>

New training approaches have been tried, such as establishing a six-year-system for the higher pharmaceutical education, enrolling middle-school graduates and granting them a Master-Degree after graduation. The characteristics of this system are as follows: (i) it shortens the length of study period (less than one year); (ii) continuous study avoids the repetition of some courses, strengthens the foundation and broadens the knowledge range; (iii) this basic training approach is course/subject oriented, so that the advantages of the skills of teachers and the academic departments are fully taken; and (iv) in the first 4.5–5 years the students finish the courses of under-/post-grad study, then write their thesis under the direction of advisors in the following 1-1.5 years.<ref>The National Centre for Education Development Research State Education Commission of P.R.C., The Development and Reform of Education in China, 36-53(1989)</ref>

== Pharmacy schools and programs ==
The pharmacy schools in China are experiencing the dramatic changes, together with the booming economy and continuous education reform. In the last ten years, one major structural change in the higher educational system was the merger of several medical and pharmacy schools with several major universities. The environment for these pharmacy schools have been changing dramatically from independent or medical university settings into being affiliated to comprehensive and [[multidisciplinary]] Universities. It presented the similar situation as those happened in the US during last century, when some state universities expanded into pharmacy education or merged with independent pharmacy schools.

There are 51 pharmaceutical institutions of higher learning (including universities and colleges) in China according to the statistics made by the end of 1995. Within these 51 institutions there are 95 programs which have enrolled 3,968 state-planned undergraduate students. In 1995 more students were enrolled in some specialties than in 1990 because of the rapid development of the health and medical economies in China which need more personnel in the fields of pharmacy. The number of the students studying various specialties increased greatly, e.g., [[pharmaceutical analysis]] by 64.5 percent, [[microbial pharmacy]] by 122 percent, [[pharmacology]] of traditional Chinese pharmacy by 200 percent, management of medical and pharmaceutical enterprises by 300 percent and [[pharmaceutics]] of traditional Chinese [[materia medica]] by 64.2 percent.

===List===
*[http://daxue.learning.sohu.com/major_detail_124.html Reference] (Chin.)
Anhui:
*[[Anhui Medical University]]
*[[Bengbu School of Medicine]]
*[[Southern Anhui Medical College]]

Beijing:
*[[Peking University]], [[Peking University Health Science Center]] - School of Pharmaceutical Sciences
*[[Capital Medical University]] (CMU)

Chongqing:
*[[Chongqing University]]
*[[Southwest Agricultural University]]
*[[Chongqing Medical University]]

Fujian:
*[[Putian Institute]]
*[[Xiamen University]]
*[[Fujian Medical University]]

Guangxi:
*[[Guangxi Medical University]]
*[[Guilin Medical College]] - Department of Pharmacy

Guangdong:
*[[Sun Yat-sen University]]
*[[Jinan University]]
*[[Guangdong Medical College]]
*[[Guangzhou Medical College]]
*[[Guangdong College of Pharmacy]] - Department of Pharmacy
*[[Jiaying College]]

Guizhou:
*[[Guiyang Medical College]] - Department of Pharmacy

Gansu:
*[[Lanzhou University]]
*[[Lanzhou Medical College]] - Department of Pharmacy

Hebei:
*[[Hebei University]]
*[[Hebei Medical University]]
*[[Hebei University of Science and Technology]]
*[[North China Coal Medical College]]
*[[Hebei North University]]
*[[Hebei Medical College]] - Department of Pharmacy

Henan:
*[[Zhengzhou University]]
*[[Henan University]]
*[[Xinxiang Medical College]]
*[[Yellow River Technical College]]
*[[Kaifeng Medical Specific School]] - Department of Pharmacy

Heilongjiang:
*[[Harbin Medical University]]
*[[Northeast Agricultural University]]
*[[Jiamusi University]]
*[[Harbin University of Commerce]]
*[[Mudanjiang Medical College]]
*[[Qiqihar Medical School]]
*[[Jiamusi Medical College]] - Department of Pharmacy

Hong Kong:
*[[Chinese University of Hong Kong]] - School of Pharmacy [http://www.pharmacy.cuhk.edu.hk/]
*[[School of Chinese Medicine at Hong Kong Baptist University]] [http://www.hkbu.edu.hk/~scm/course/eng/fulltime_32.html]
*[[Li Ka Shing Faculty of Medicine]], [[The University of Hong Kong]] [http://www.hku.hk/facmed/images/document/03edu/undergrad/BPharm.pdf]

Hubei:
*[[Huazhong University of Science and Technology]]
*[[Wuhan University]] - College of Pharmacy
*[[Wuhan University of Science and Technology]]
*[[Zhongnan University of Nationalities]]
*[[Hebei Medical College]] - Department of Pharmacy
*[[Xianning College]]
*[[Yunyang School of Medicine]]
*[[Tongji Medical University]] - School of Pharmaceutical Sciences

Hunan:
*[[Central South University]]
*[[Xiangtan University]]
*[[Hunan Agricultural University]]
*[[South China University]]
*[[Central South Forestry University]]
*[[Hunan Medical Specific School]] - Department of Pharmacy

Jiangsu:
*[[Soochow University (Suzhou)|Soochow University]]
*[[Jiangsu University]]
*[[China Pharmaceutical University]] ([[Nanjing]])
*[[Nanjing Medical University]]
*[[Xuzhou Medical College]]
*[[Naval Medical Specific School]] - Department of Pharmacy

Jiangxi:
*[[Nanchang University]]
*[[Jiangxi Medical College]]
*[[Yichun College]]
*[[Jiangxi Science and Technology Teachers College]]
*[[Jinggangshan College]]
*[[Southern Jiangxi Medical College]]

Jilin:
*[[Changchun Institute of Oriental career]]
*[[Jilin University]]
*[[University of North]]
*[[Yanbian University]]
*[[Yanbian Medical College]] ([[Yanji]]) - Department of Pharmacy

Liaoning:
*[[China Medical University (PRC)|China Medical University]]
*[[Shenyang Pharmaceutical University]]
*[[Dalian Medical University]]
*[[Jinzhou School of Medicine]]
*[[Shenyang College of Pharmacy]]

Macau:
*[[Macao Polytechnic University]] - Faculty of Health Sciences and Sports [https://www.ipm.edu.mo/escsd/] (pharmacy technician training)

Neimeng:
*[[Inner Mongolia University of Science and Technology]]
*[[Inner Mongolia Medical College]] - Department of Pharmacy

Ningxia:
*[[Ningxia Medical College]]

Qinghai:
*[[Qinghai University]]
*[[Qinghai Institute for Nationalities]]

Shaanxi:
*[[Xi'an Jiaotong University]]
*[[Xian Medical University]] - School of Pharmaceutical Sciences

Shanxi:
*[[Shanxi University]]
*[[Shanxi Medical University]]
*[[Changzhi School of Medicine]]
*[[Shanxi Medical College]] - Department of Pharmacy

Shandong:
*[[Shandong University]]
*[[Ocean University of China]]
*[[Yantai University]]
*[[Tai Shan Medical College]]
*[[Jining Medical College]]
*[[Shandong Medical College]] - Department of Pharmacy

Shanghai:
*[[East China University of Science and Technology]] - School of Pharmacy
*[[Fudan University]]
*[[Shanghai Jiaotong University]]
*[[Shanghai Medical University]] - School of Pharmacy
*[[Shanghai Second Medical University]]
*[[Shanghai Polytechnic University]]
*[[Second Military Medical University]] - Department of Pharmacy

Sichuan:
*[[Sichuan University]]
*[[Sichuan Agricultural University]]
*[[Luzhou Medical College]]
*[[North Sichuan Medical College]]
*[[West China Medical University]] - School of Pharmaceutical Sciences

Tianjin:
*[[Tianjin University]]
*[[Nankai University]]
*[[Tianjin Medical University]]
*[[Tianjin University of Technology]]
*[[Second Tianjin Medical College]] - Department of Pharmacy

Xinjiang:
*[[Shihezi University]]
*[[Xinjiang Agricultural University]]
*[[Xinjiang Medical University]]
*[[Shihezi Medical College]] - Department of Pharmacy
*[[Xinjiang Medical College]] - Department of Pharmacy

Yunnan:
*[[Kunming Medical College]]
*[[Dali College]]
*[[Yuxi Teachers College]]

Zhejiang:
*[[Zhejiang University]]
*[[Zhejiang University of Technology]]
*[[Wenzhou Medical College]]
*[[Hangzhou Teachers College]]
*[[China Institute of Measurement]]
*[[Shaoxing College of Arts and Pharmacy]]
*[[Zhejiang Medical University]] - Department of Pharmacy

===TCM colleges===

*[[Anhui Chinese Medicine College]]
*[[Beijing College of Traditional Chinese Medicine]]
*[[Changchun University of Traditional Chinese Medicine]]
*[[Chengdu College of Traditional Chinese Medicine]]
*[[Guangxi College of Traditional Chinese Medicine]]
*[[Guangzhou College of Traditional Chinese Medicine]]
*[[Guiyang College of Traditional Chinese Medicine]]
*[[Heilongjiang College of Traditional Chinese Medicine]]
*[[Heilongjiang Commerce College]]
*[[Henan College of Traditional Chinese Medicine]]
*[[School of Chinese Medicine at Hong Kong Baptist University]]
*[[Hubei College of Traditional Chinese Medicine]]
*[[Hunan University of Traditional Chinese Medicine]]
*[[Jiangxi Chinese Medicine College]]
*[[Jiangxi College of Traditional Chinese Medicine]]
*[[Liaoning College of Traditional Chinese Medicine]]
*[[Nanjing University of Traditional Chinese Medicine]]
*[[Shandong College of Traditional Chinese Medicine]]
*[[Shanghai College of Traditional Chinese Medicine]]
*[[Tianjin University of Traditional Chinese Medicine]]
*[[Shanxi College of Traditional Chinese Medicine]]
*[[Yunnan College of Traditional Chinese Medicine]]
*[[Zhejiang College of Traditional Chinese Medicine]]

== Licensing and regulation ==
To practice pharmacy in China in which a license is required, an applicant must be qualified by graduation from a recognized college of pharmacy, meet specific requirements for experience, and pass an examination conducted by the [[Chinese Pharmaceutical Association]] as appointed by the government.

Pharmacy [[law]]s generally include the regulations for the practice of pharmacy, the sale of liquids, the dispensing of narcotics, and the labeling and sale of dangerous drugs. The pharmacist sells and dispenses drugs within the provisions of the food and drug laws of the country in which he practices. These laws recognize the national [[pharmacopoeia]] (which defines products used in medicine, their purity, dosages, and other pertinent data) as the standard for drugs.

Regulatory bodies with responsibilities related to pharmacy are:
*[[General Administration of Quality Supervision, Inspection and Quarantine]]
*[[Ministry of Health of the People's Republic of China|Ministry of Health]]
*[[State Food and Drug Administration]]
*[[National Institute for the Control of Pharmaceutical and Biological Products]]
*[[Ministry of Agriculture]]

== Research ==
Pharmaceutical research, in Chinese schools of pharmacy, embraces the [[organic chemistry|organic chemical]] synthesis of new chemical agents for use as drugs and is also concerned with the isolation and purification of plant constituents that might be useful as drugs. Research in pharmacy also includes formulation of dosage forms of medicaments and study of their stability, methods of [[assay]], and [[standardization]].

Another facet of pharmaceutical research that has attracted wide medical attention is the "availability" to the body ([[bioavailability]]) of various [[dosage form]]s of drugs. Exact methods of determining levels of drugs in blood and organs have revealed that slight changes in the mode of manufacture or the incorporation of a small amount of [[Chemically inert|inert]] ingredient in a tablet may diminish or completely prevent its absorption from the gastrointestinal tract, thus nullifying the action of the drug. Ingenious methods have been devised to test the bioavailability of dosage forms. Although such [[in vitro]], or test-tube, methods are useful and indicative, the ultimate test of bioavailability is the patient's response to the dosage form of the drug.

Licensing systems for new medicinal products in China demand  increasingly extensive and costly investigation and testing in the laboratory and in [[clinical trial]]s to establish the efficacy and safety of new products in relation to the claims to be made for their use. Proprietary rights for innovation by the grant of patents and by the registration of trademarks have become increasingly important in the growth of the domestic pharmaceutical industry and its development internationally.

===Journals===
*[http://www.periodicals.net.cn/eqikan.asp?codeID=R9 Catalog Periodical List] "Pharmaceutics" - Wangfang Data

The results of research in pharmacy are usually published in such journals as the:
*''Acta Pharmaceutica Sinica''
*''Adverse Drug Reaction Journal''
*''China Journal of Traditional Chinese Medicine and Pharmacy''
*''China Pharmaceutical Journal''
*''China Pharmacist''
*''China Pharmacy''
*''Chinese Journal of Antibiotics''
*''Chinese Journal of Clinical Pharmacy''
*''Chinese Journal of Drug Application and Monitoring''
*''Chinese Journal of Hospital Pharmacy''
*''Chinese Journal of Modern Applied Pharmacy''
*''Chinese Journal of Natural Medicines''
*''Chinese Journal of New Drugs''
*''Chinese Journal of New Drugs and Clinical Remedies''
*''Chinese Journal of Pharmaceutical Analysis''
*''Chinese Journal of Pharmaceuticals''
*''Chinese Journal of Pharmacoepidemiology''
*''Chinese Pharmaceutical Journal''
*''Chinese Traditional and Herbal Drugs''
*''Herald of Medicine''
*''Journal of Beijing University of Traditional Chinese Medicine''
*''Journal of China Pharmacy'' (monthly; currently reaches 12,000 hospital pharmacies, being read by some 200,000 pharmacists nationwide.[http://www.china-pharmacy.com/en-en/Affiche/ShowAffiche.aspx?ID=1])
*''Journal of China Pharmaceutical University''
*''Journal of Chinese Materia Medica''
*''Journal of Traditional Chinese Medicine''
*''Pharmaceutical Care and Research''
*''Pharmaceutical Education''
*''Asian Journal of Social Pharmacy''

''Asian Journal of Pharmaceutical Sciences'' was founded jointly by Shenyang Pharmaceutical University and China Medicine Technical International Development Association.  The journal is published 6 issues per year by Hong Kong Asiamed Publishing House in English for international distribution. There is no page charge, but cost of translation and English may be levied when necessary.

;Retail pharmacy
*[http://www.ydzz.com/ China Drug Store] industry magazine [http://www.ilib.cn/P-zgyd.html ilib.cn]

== Organizations ==
There are numerous pharmacy-related organizations. The [[Chinese Pharmaceutical Association]] (CPA) is the national organization of pharmacists and pharmaceutical scientists with the mission to represent and serve pharmacy and pharmaceutical sciences development in China. CPA was founded in 1907, it now has nearly 3000 senior individual members and 35 group members. Through its group members, CPA connects, represents and serves more than 105,000 pharmacists and pharmaceutical scientists around the country. The CPA is a member of the International Pharmaceutial Federation.

There are also other societies in which history, teaching, and the military aspects of pharmacy are given special emphasis.

== Retail (community) pharmacy ==
About 120,000 retail pharmacies operate in China. Most of them are quite small—less than 200 m<sup>2</sup>—but a few are as large as 1,000 m<sup>2</sup> or more. The majority are licensed to carry medicines (prescription and over-the-counter [OTC]), traditional Chinese medicines, health foods (designated by the jian shi characters at the beginning of the registration certificate), and family planning products. Some retail pharmacies are also licensed to carry cosmetic products. It is relatively simple to add products the Chinese government classifies as cosmetics to a pharmacy's operating license. Chinese retail pharmacies do not carry products frequently found in US pharmacies, such as shampoo, diapers, nail polish, and batteries. China's pharmacies, however, sell products such as imported skin creams, specialty hair-care products (such as dyes or masks), and feminine-hygiene products.

All retail pharmacies prior to January 2003 -– when WTO rules took effect – had by law must have been government-owned. Many of the state-owned pharmacy companies had consolidated to establish chains or franchises, and many more have contracted day-to-day management to an entrepreneur who pays a small percentage of the profits to its hands-off government owner. In Beijing and Shanghai, the local governments stopped approving applications for new pharmacies about three years ago, but is allowing chain stores to increase their number of outlets. Therefore, any "new" retail pharmacy in these markets must be affiliated with an existing outlet. In Shanghai, pharmacies must also contend with a rule that prohibits chains from opening outlets within a certain distance of existing pharmacies.

Local administrations for industry and commerce and local health bureaus oversee and regulate the pharmacies. Their monitoring of retail outlets includes spot checks of the types of products being sold, follow-ups on consumer complaints, and verification that retail prices match registered prices. Government monitors also verify that products comply with government regulations on labeling and other matters, and that merchandising and advertising materials are compliant and registered.

Chinese pharmacies have been undergoing dramatic changes as the retail medicine market opens up. Under planned reforms, China's retail pharmacies will begin selling a much higher volume of prescription drugs, and hospital pharmacies will eventually be restricted to dispensing prescriptions for inpatient use. Retail pharmacies' businesses will consist more and more of high-volume prescription drug sales and high-margin healthcare and personal-care products, including OTC drugs, health foods, family planning products, and beauty products, similar to a European or North American drugstore model.

More and more patients have been willing to buy non-prescription medicines in convenient drugstores instead of registering and queuing in hospitals. Large numbers of drug wholesalers have also entered the retail market due to the expected returns. Domestic pharmaceutical giant Sanjiu Enterprise Group has planned to open 8,000 to 10,000 outlets at a cost of 1.3 billion yuan (US$157 million).

[[China Nepstar]] is the largest retail drugstore chain in China, based on the number of directly operated stores. As of September 2007, the company had 1,791 stores in 62 cities. Nepstar has also planned to establish 5,000 to 10,000 chain stores in the next five years. It provides pharmacy services as well as a wide variety of other merchandise, including [[over-the-counter drug]]s, herbal products, personal care products and nutritional supplements. The company also offers 1,108 private-label products under its own brand name. For the six months ended June 30, China Nepstar reported earnings of $4.6 million, after paying preferred dividends, on sales of $124.3 million.<ref>[http://biz.yahoo.com/ap/071109/china_nepstar_chain_drugstore_ipo.html?.v=1 China Nepstar Shares Gain in Debut]</ref>

As of 2003, China had 196 pharmaceutical enterprises with chain stores, reporting an annual sales volume of nearly 8 billion yuan (US$967 million). Most chain drugstores though are small in scale. Peace Pharmacy, one of China's largest drug store in [[Chongqing]] had only 300 chain stores. Besides medicines, medical equipment are also sold in Chinese drugstores. This has been to meet the demand of consumers who have begun to favor products for self-diagnosis and self-health care.

Rapid [[mergers and acquisitions]], expansion in the retail industry is expected to gradually consolidate the sector.

Pharmacies, found in all towns, can help with minor injuries and ailments. Larger ones sometimes have a separate counter offering diagnosis and advice. Staff can usually help if the customer describes his or her symptoms. The selection of reliable Asian and Western products available is improving and it is possible to self-treat with herbal medicines. Contraceptives are widely available, as are antibiotics.

===List===
The key players in the drugstore industry in China are [http://www.ydzz.com/topInfo/topDetail.asp?orderid=11]:

*PG Pharma, Shanghai
*[[China Nepstar]], Shenzhen-based
*[[SuperPharm]], Israeli company has about 65 stores in China, as of 2007
*[[Watsons]], owned HK-based Hutchison Whampoa
*Shenzhen Accord Pharmacy Co., Ltd.
*Shenzhen Associate Pharmacy Co., Ltd.
*Guangzhou Pharmaceutical Company
*Jianmin Chain Drugstore
*Guangzhou Caizhilin Chain Drugstore
*Liaoning Chengda Co., Ltd.
*Hangzhou Wulin Drugstore Co., Ltd.
*Ningbo Siming Dayaofang Co., Ltd.
*Hunan Laobaixing Big Drugstore Chain Co., Ltd.
*Hunan Zhilin Medicine (Group) Co., Ltd.
*Hubei Ready Medicine Industry Co., Ltd.
*Chongqing Tongjunge Big Drugstore Chain Co., Ltd.
*Shanghai Huashi Pharmacy Co., Ltd.
*Beijing Golden Elephant Pharmacy Chain Co., Ltd.

== Good Pharmacy Practice ==
As a result of the development of society and national economy, the people's health care level and the sense of self-medication are gradually improving. Therefore, the demand for good pharmacy service especially for carrying out pharmaceutical care not only in hospital but also in community pharmacies are increasing.

The [[China Nonprescription Medicines Association]] (CNMA) is a guild of pharmaceutical manufacturers and distributors, especially of those manufacturers of non-prescription medicines and community pharmacies.<ref>[http://www.selfmed.cn/constitution.asp China Nonprescription Medicines Association]</ref> Based on the pharmaceutical care and licensed pharmacists system, the CNMA under the auspices of government and membership units, consulted the "International Good Pharmacy Practice for Developing Countries" and the "Standards for Quality of Pharmacy Services" and GPP documents of other countries available to constitute the Good Pharmacy Practice and Evaluation Standards of GPP especially for community pharmacies.

== Pharmacoeconomics ==
Limited resources, amidst increasing demand for services, are leading to significant change in the implementation of health care in China, especially manifested lately in the pricing and reimbursement of pharmaceuticals.

Pharmaceutical expenditures can exceed 30% of total health expenditures in some poorer areas; so greater scrutiny and control over drugs are evident lately. Pharmacoeconomic research, either used when health providers examine different treatments to make cost-effective decisions, or when regulatory institutions estimate the greater value of a new product to set a reimbursement level, marks the horizon for the world's pharmaceutical markets.

[[Pharmacoeconomics]] as a science has begun to advance with methodological guidelines as it is increasingly applied in many countries.

China today must confront significant cost-containment in health care, as seen in every developing nation of the world. Pharmacoeconomic research thus will likely find favor to facilitate the evaluation of resource utilization for greater efficiency and better health outcomes in its population; however, pharmacoeconomics currently is stagnating in China due to the lack of adequate academic research centers, pharmaceutical industry investment, and government coordination.

It is predicted that China will, out of necessity, end this lag as its health care system overcomes its limitation on pharmacoeconomic knowledge and lessens influences from the old pharmaceutical [[pricing]] and [[reimbursement]] system. The upsurge import of more Western drugs now with the [[World Trade Organization]] (WTO) entry is another force leading to China's eventual progress in this area.

Current applications within a few industrialized countries can serve as a prelude to describing lessons for and reforms taking place in China. There are encouraging, although not yet significant, steps being taken to embed more pharmacoeconomics into the Chinese health care system.<ref>Journal of Pharmaceutical Finance, Economics & Policy</ref>

===Research institutions===
The [[China Center for Pharmacoeconomics and Outcomes Research]] (CCPOR) is a newly established research institution based in the Department of Health Economics and Management at the [[Peking University]] [[Guanghua School of Management]].[http://mba.pku.edu.cn/xwzx/mbanews/040802_1.htm]

[[Fudan Center for Pharmacoeconomic Research and Evaluation]] (CPRE)[http://sph.fudan.edu.cn/pe/about_en.jsp] of [[Fudan University]] in Shanghai.

[http://www.pe-cn.org/ Pharmacoeconomics China] or Chinese PharmacoEconomics Guidelines Project - Chinese Medical Doctor Association is the executive center of this project, and the center specializes in Chinese PharmacoEconomics Guidelines to improve the development of PharmacoEconomic assessment and clinical rational drug usage in China

==Counterfeit drugs==
Figures in China report almost 200,000 persons are said to have died in 2001 as a consequence of having taken [[counterfeit drug]]s.<ref>[http://www.gphf.org/web/en/historie/news0203.htm GPHF NEWS II / 2003]</ref>

There are major difficulties for patients accessing expensive pharmaceuticals which encourage smuggling and even home manufacture.  The state healthcare system does not cover many drugs, and for those that are covered there is a 30% [[copayment]]. The approval process is slow and bureaucratic.  Only 100 new drugs were approved between 2001 and 2016 by the [[China Food and Drug Administration]].  Once approved, drugs have to be included in the National Reimbursement Drug List to qualify for coverage.  Prices are much higher than in other Asian countries.<ref>((cite news |title=In China, Desperate Patients Smuggle Drugs. Or Make Their Own. |url=https://www.nytimes.com/2018/11/11/business/china-drugs-smuggled-homemade.html |access-date=22 December 2018 |work=New York Times |date=11 November 2018))</ref>

==Online and mail-order pharmacies==
((See also|Online pharmacy))
Online pharmacies were first established in China in 2005. By the end of 2008, only 10 online pharmacies had obtained permission to sell [[over-the-counter drug]]s,<ref>((Cite web|url=http://tech.qq.com/a/20081209/000023.htm|title=国家药监局：全国只有10家网上药店合法))</ref> a figure that had increased to 639 by January, 2017.<ref>((Cite web|url=http://app1.sfda.gov.cn/datasearch/face3/dir.html|title=国家食品药品监督管理局：企业查询 (in Chinese)))</ref> Online sales increased in line with the number of pharmacies. The China Food and Drug Administration conducted a pilot reform to admit three businesses using their third-party platform to retail drugs online to consumers from 2013 until August 2016, accounting for to some extent difficulty in its regulation.<ref>((Cite web|url=http://news.xinhuanet.com/fortune/2016-08/01/c_129195821.htm|archive-url=https://web.archive.org/web/20160802171606/http://news.xinhuanet.com/fortune/2016-08/01/c_129195821.htm|url-status=dead|archive-date=August 2, 2016|title=互联网第三方平台售药试点结束 后续经营需获资格证书 (in Chinese)))</ref>

==International facilities==
The [[U.S. Pharmacopeia]] has an international facility in [[Shanghai]]'s Zhangjiang Hi-Tech to work with Chinese companies and regulators on meeting international standards and ensuring the safety of pharmaceuticals, dietary supplements and ingredients. It opened in 2006 and was inaugurated in 2007.<ref>[http://chccgroup.com/index.php?option=com_content&task=view&id=57&Itemid=70 U.S. Pharmacopeia Inaugurates New Facility in Shangha - China HealthCare Group<!-- Bot generated title -->]</ref> (See: [http://www.usp.org/aboutUSP/newsletter.html USP-China Quarterly Update])

== Museums ==
*The Museum of Huqingyutang Chinese Pharmacy

== See also ==
* [[Chinese Pharmaceutical Association]]
* [[Campaign for Access to Essential Medicines]]
* [[Collaborating Centre on International Drug Monitoring in Uppsala]]
* [[Department of Essential Drugs and Medicines]]
* [[Evidence-based pharmacy in developing countries]]
* [[Essential medicines]]
* [[Good pharmacy practice]]
* India's [[National Institute of Pharmaceutical Education & Research]]
* [[List of pharmacy associations]]
* [[List of World Health Organization Essential Medicines]]
* [[Pharmaceutical industry in China]]
* [[State Food and Drug Administration]]
* [[Public health in China]]
* [[Pharmaceutical policy]], [[national pharmaceuticals policy]]
* [[Pharmacies of Norway]], for a country comparison
* [[Pharmacy Council of India]]
* [[National Formulary]]
* [[Universities Allied for Essential Medicines]]

==References==
((reflist))
*[http://www.pharmacy.wsu.edu/history/index.html A History of Pharmacy in Pictures] College of Pharmacy, Washington State University
*[http://www.fip.org/www2/education/index.php?page=pharmacy_education&pharmacy_education=pe_wlops_cf_china  China] World List of Pharmacy Schools, International Pharmaceutical Federation (FIP)
*[http://www.chinabusinessreview.com/public/0109/pharmacies.html Reaching China's Middle Class Through Retail Pharmacies] - China Business Review 2001
*Zhu, Yi-Zhun., Zhou, FangMing., Lu, Wei-Yue., Ye, DeYong. and ZHENG, HaiAn.  "A Comparison Study between Independent and University-affiliated Pharmacy Schools in China -- Does University Setting Benefit Pharmacy Education?" Paper presented at the annual meeting of the American Association of Colleges of Pharmacy, Sheraton San Diego Hotel & Marina, San Diego, California, USA, Jul 05, 2006.
*HC Wang, LY Chen, and AH Lau. ''Pharmacy practice and education in the People's Republic of China''. 1993  The Annals of Pharmacotherapy: Vol. 27, No. 10, pp.&nbsp;1278–1282.
*GJ Liu. ''Hospital pharmacy practice in the People's Republic of China''. (1982) American Journal of Hospital Pharmacy, Vol 39, Issue 9, 1487–1490
*Chen Zongmin. "[http://www.ajpe.org/legacy/ajpe_metaview.asp?ID=801 The development of higher pharmaceutical education in China's reform]", Institute of Pharmaceutical Education, [[China Pharmaceutical University]], Nanjing, Jiansu. [[American Association of Colleges of Pharmacy]]. Spring 1998.
*Qian Cai, J. Warren Salmon. "What Role May Pharmacoeconomics Play in Pharmaceutical Pricing and Reimbursement in China?" ''Journal of Pharmaceutical Finance, Economics & Policy (Volume 4 Number 1, 2005)

== Further reading ==
*[http://www.historycooperative.org/journals/hah/6.1/liping.pdf Professional Code or Legal Sanctions: Pharmacy in China] by Du Liping, University of Melbourne (Health & History, 2004. 6/1: 87–96)
*[http://www.pjonline.com/Editorial/20011222/christmas/hongkong.html Pharmacy in Hong Kong] The Pharmaceutical Journal Vol 267 No 7179 p911-936; 22–29 December 2001
*[http://www.fip.nl/www2/pdf/gpp/GPP_CPS_Report.pdf Good Pharmacy Practice (GPP) in Developing Countries]
*[http://isi.cbs.nl/iamamember/CD2/pdf/541.PDF Public health development of China] Shandong Statistical Bureau
*[http://www.ajpe.org/legacy/ajpe_metaview.asp?ID=518 An important task of the 21st century: Strengthening international exchange and cooperation in pharmaceutical education] Zongmin, Chen,  Na, Li, Taikang, Huang. American Journal of Pharmaceutical Education. Vol. 64, No. 2 (2000)
*[http://www.ajpe.org/legacy/pdfs/aj640414.pdf Integrating R&D with Manufacturing and Pharmaceutical Education in China] Wang Qiang, Shi Zhixiang, and Chen Zongmin. American Journal of Pharmaceutical Education. Vol. 64, No. 4 (2000)
*[http://www.ajpe.org/legacy/ajpe_metaview.asp?ID=932 The Teaching Contents and Methods of International Pharmaceutical Business] Ma Aixia. American Journal of Pharmaceutical Education. Vol. 65, No. 3 (2001)
*[http://www.ajpe.org/legacy/ajpe_metaview.asp?ID=1073 Deepening the Reform of Higher Pharmaceutical Education for the 21st Century] Xiaoming Wu. American Journal of Pharmaceutical Education. Vol. 64, No. 3 (2000)

;Pharmacovigilance
*Wang Yue et al. [http://iospress.metapress.com/content/r4k7xv2454h20761/ Regional pharmacovigilance practice in China] ''The International Journal of Risk and Safety in Medicine'' Volume 20, Number 1-2 / 2008 pp.&nbsp;51–56
*Zhou Yibing et al. [http://www.ingentaconnect.com/content/adis/ipm/2006/00000020/00000002/art00001 An Overview of Adverse Drug Reaction Monitoring in China] ''International Journal of Pharmaceutical Medicine'', Volume 20, Number 2, 2006 , pp.&nbsp;79–85(7)

;Pharmacoeconomics
*[http://www.ispor.org/conferences/shanghai0306/pdf/02-China-Hu.pdf Pharmacoeconomics and Outcome Research in China] Shanlian Hu. MD. MSc. ProfessorSchool of Public Health, Fudan University, ISPOR 2nd Asia-Pacific Conference, March 6, 2006.
*Liu G.G.; Liu C. [http://www.ingentaconnect.com/content/adis/pdr/2003/00000001/00000003/art00003;jsessionid=52iijv67sg9oi.alice?format=print Potential Expanded Use of Pharmacoeconomics and Outcomes Research in China] ''Pharmaceutical Development and Regulation'', Volume 1, Number 3, 2003 , pp.&nbsp;169–177(9)
*Liu Bao Peng; Chong Qing Tan; Xiao Min Wan; Cui, Wei. "[[Cost-Utility Analysis]] in China: Differences and Difficulties Compared with Developed Countries". ''[[PharmacoEconomics (journal)|PharmacoEconomics]]'', Volume 25, Number 7, 2007, pp.&nbsp;619–619(1)

== External links ==
* [http://www.capc.org.cn/ China Association of Chain Drug Stores]
*[http://www.cpahp.org.cn/ Chinese Pharmaceutical Association Committee on Professional Hospital Pharmacy]
*[http://www.phr.com.cn/ Clinical Pharmacy Network in China]
*[http://www.winpharm.net/ WinPharm]
*[http://www.yxbj.com yxbj.com]
*[http://www.china-pharmacy.com China Pharmacy Network]
*[http://www.yaodianwang.com Chinese Pharmacy Network]
*[http://www.rcvagroup.com/images/mmr_china.pdf China: Where East Meets West] China's pharmacy chain drug stores, RCVA Group
*[http://www.mcmia.org/ Modernized Chinese Medicine International Association] (MCMIA)
*[http://www.weibiao.cn/ BeiJing WEIBIAO Center For Drug Standard Research Development]
*[http://www.china.org.cn/english/education/218544.htm China to Improve Standards of Pharmacy Degrees for Overseas Students] (Xinhua; July 26, 2007)
*[http://www.australianprescriber.com/magazine/26/6/128/30/ The quality and safety of traditional traditional Chinese medicines] (Aust Prescr 2003;26:128-30)
*[http://www.usp.org/pdf/EN/dqi/fakeAntimalarialsinChina.pdf Fake Anti-malarials found in Yunnan Province, China] USP, Drug Quality and Information Program

;Chinese pharmaceutical policy
*[https://archive.today/20090514020103/http://healthtech.who.int/tbs/ChinesePharmaceuticalPolicy/BackgroundENGdefault.htm Chinese Pharmaceutical Policy Studies] - WHO Health Systems and Services, Medicines and Health Technologies

;International conferences
*[http://www.accp7.com/en/lisi.html The 7th Asian Conference on Clinical Pharmacy] July 2007, Shanghai
*[http://www.fip.org/CONGRESS/beijing2007/?id=600 67th International Congress of FIP] World Congress of Pharmacy and Pharmaceutical Sciences
*[http://www.industrialpharmacy.org/beijing2007/introduction.html Industrial Pharmacy section]
*[http://193.13.86.21/curriculum.php Pharmaceutical Curriculum Development: An evolutionary or a revolutionary process?] Pre-PSWC2007 Workshop (April 21, 2007)

;People
*[http://pharmacy.umich.edu/morenews/college/john_liu/bridge_builder.html CELEBRATED BRIDGE–BUILDER PASSES ON, BUT LIFE WORK CONTINUES] Guo-jie John Liu, MSPharm'50: January 9, 1915 – March 21, 2006 ([[University of Michigan College of Pharmacy]])
*[https://archive.today/20130209162828/http://news.xinhuanet.com/english/2008-07/18/content_8567353.htm White paper: 150,000 people in China obtain pharmacist's qualifications] Xinhua 2008-07-18

;Comparative study
*[http://www.ordre.pharmacien.fr/upload/Syntheses/254.pdf China / European Union: Overview of Community Pharmacy]

((Health in the People's Republic of China|state=expanded))
((Asia topic|Pharmacy in))
((Pharmacy))

((DEFAULTSORT:Pharmacy In China))
[[Category:Pharmacies of China| ]]
[[Category:Industry in China]]
[[Category:Healthcare in China]]

Pages transcluded onto the current version of this page (help):

Pharmacy in China (edit)
Template:Ambox (view source) (template editor protected)
Template:Asia topic (view source) (template editor protected)
Template:Cite news (view source) (protected)
Template:Cite web (view source) (protected)
Template:Cleanup rewrite (view source) (template editor protected)
Template:Find sources mainspace (view source) (template editor protected)
Template:Health in China (edit)
Template:Health in the People's Republic of China (edit)
Template:Hlist/styles.css (view source) (protected)
Template:Icon (view source) (template editor protected)
Template:Iso2country (view source) (template editor protected)
Template:Iso2country/article (view source) (template editor protected)
Template:Iso2country/data (view source) (template editor protected)
Template:Main other (view source) (protected)
Template:More citations needed (view source) (template editor protected)
Template:Multiple issues (view source) (template editor protected)
Template:Multiple issues/styles.css (view source) (template editor protected)
Template:Navbox (view source) (template editor protected)
Template:Pharmacy (edit)
Template:Reflist (view source) (protected)
Template:Reflist/styles.css (view source) (protected)
Template:See also (view source) (template editor protected)
Module:Arguments (view source) (protected)
Module:Category handler (view source) (protected)
Module:Category handler/blacklist (view source) (protected)
Module:Category handler/config (view source) (protected)
Module:Category handler/data (view source) (protected)
Module:Category handler/shared (view source) (protected)
Module:Check for unknown parameters (view source) (protected)
Module:Citation/CS1 (view source) (protected)
Module:Citation/CS1/COinS (view source) (protected)
Module:Citation/CS1/Configuration (view source) (protected)
Module:Citation/CS1/Date validation (view source) (protected)
Module:Citation/CS1/Identifiers (view source) (protected)
Module:Citation/CS1/Utilities (view source) (protected)
Module:Citation/CS1/Whitelist (view source) (protected)
Module:Citation/CS1/styles.css (view source) (protected)
Module:Find sources (view source) (template editor protected)
Module:Find sources/config (view source) (template editor protected)
Module:Find sources/links (view source) (template editor protected)
Module:Find sources/templates/Find sources mainspace (view source) (template editor protected)
Module:Format link (view source) (template editor protected)
Module:Hatnote (view source) (template editor protected)
Module:Hatnote/styles.css (view source) (template editor protected)
Module:Hatnote list (view source) (template editor protected)
Module:Icon (view source) (template editor protected)
Module:Icon/data (view source) (template editor protected)
Module:Labelled list hatnote (view source) (template editor protected)
Module:Message box (view source) (protected)
Module:Message box/ambox.css (view source) (protected)
Module:Message box/configuration (view source) (protected)
Module:Namespace detect/config (view source) (protected)
Module:Namespace detect/data (view source) (protected)
Module:Navbar (view source) (protected)
Module:Navbar/configuration (view source) (protected)
Module:Navbar/styles.css (view source) (protected)
Module:Navbox (view source) (template editor protected)
Module:Navbox/configuration (view source) (template editor protected)
Module:Navbox/styles.css (view source) (template editor protected)
Module:String (view source) (protected)
Module:Unsubst (view source) (protected)
Module:Yesno (view source) (protected)

Return to Pharmacy in China.

Retrieved from "https://en.wikipedia.org/wiki/Pharmacy_in_China"